MarÃn-Liébana, S.; Llor, P.; Serrano-GarcÃa, L.; Fernández-Murga, M.L.; Comes-Raga, A.; Torregrosa, D.; Pérez-GarcÃa, J.M.; Cortés, J.; Llombart-Cussac, A.
Gene Expression Signatures for Guiding Initial Therapy in ER+/HER2- Early Breast Cancer. Cancers 2025, 17, 1482.
https://doi.org/10.3390/cancers17091482
AMA Style
MarÃn-Liébana S, Llor P, Serrano-GarcÃa L, Fernández-Murga ML, Comes-Raga A, Torregrosa D, Pérez-GarcÃa JM, Cortés J, Llombart-Cussac A.
Gene Expression Signatures for Guiding Initial Therapy in ER+/HER2- Early Breast Cancer. Cancers. 2025; 17(9):1482.
https://doi.org/10.3390/cancers17091482
Chicago/Turabian Style
MarÃn-Liébana, Sara, Paula Llor, LucÃa Serrano-GarcÃa, MarÃa Leonor Fernández-Murga, Ana Comes-Raga, Dolores Torregrosa, José Manuel Pérez-GarcÃa, Javier Cortés, and Antonio Llombart-Cussac.
2025. "Gene Expression Signatures for Guiding Initial Therapy in ER+/HER2- Early Breast Cancer" Cancers 17, no. 9: 1482.
https://doi.org/10.3390/cancers17091482
APA Style
MarÃn-Liébana, S., Llor, P., Serrano-GarcÃa, L., Fernández-Murga, M. L., Comes-Raga, A., Torregrosa, D., Pérez-GarcÃa, J. M., Cortés, J., & Llombart-Cussac, A.
(2025). Gene Expression Signatures for Guiding Initial Therapy in ER+/HER2- Early Breast Cancer. Cancers, 17(9), 1482.
https://doi.org/10.3390/cancers17091482
